Cytosorbents
CTSO
#9821
Rank
NZ$79.87 M
Marketcap
NZ$1.27
Share price
4.11%
Change (1 day)
-32.59%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -NZ$22.55 Million

According to Cytosorbents's latest financial reports the company's current earnings are NZ$36.97 Million. In 2024 the company made an earning of -NZ$39.6 Million, an increase over its 2023 earnings that were of -NZ$51.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$22.55 Million-43.05%
2024 -NZ$39.6 Million-22.49%
2023 -NZ$51.09 Million-13.52%
2022 -NZ$59.08 Million34.04%
2021 -NZ$44.08 Million182.17%
2020 -NZ$15.62 Million-55.97%
2019 -NZ$35.47 Million14.17%
2018 -NZ$31.07 Million95.14%
2017 -NZ$15.93 Million-22.32%
2016 -NZ$20.5 Million39.1%
2015 -NZ$14.74 Million-12.89%
2014 -NZ$16.92 Million89%
2013 -NZ$8.95 Million26.65%
2012 -NZ$7.07 Million-26.02%
2011 -NZ$9.56 Million-288.45%
2010 NZ$5.06 M-4.17%
2009 NZ$5.28 M-287.19%
2008 -NZ$2.83 Million-47.12%
2007 -NZ$5.35 Million41.78%
2006 -NZ$3.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
NZ$96.7 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$1.39 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$5.69 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA